Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3

1(33.3%)

Phase 4

1(33.3%)

N/A

1(33.3%)

3Total

Phase 3(1)

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07195331Phase 4Recruiting

Comparison Between Standard and Reduced Doses of Indocyanine Green in Fluorescence Cholangiography During Laparoscopic Cholecystectomy.

Role: collaborator

NCT06783491Phase 3Not Yet Recruiting

Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Colon Cancer

Role: collaborator

NCT05334173Not ApplicableActive Not Recruiting

Gastric Bypass With Different Lengths of the Bilipancreatic Limb

Role: collaborator

NCT05643105Unknown

Anastomotic Leakage After Colon Cancer Surgery

Role: collaborator

NCT05369988Unknown

VALIDATION OF THE VIBe INTRAOPERATIVE BLEEDING SCALE IN LIVER SURGERY

Role: collaborator

NCT05300789Completed

Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer Patients

Role: collaborator

NCT04817813Unknown

Long-term Outcomes After Breast Cancer Liver Metastasis Surgery: an European, Retrospective, Snapshot Study

Role: collaborator

NCT04683783Completed

National Registry of Liver First Approach

Role: collaborator

All 8 trials loaded